Centauri Therapeutics Secures $5.1 Million from CARB-X to Advance Antimicrobial Immunotherapy
Centauri Therapeutics, a UK-based immunotherapy company specializing in antimicrobial resistance (AMR) treatments, has secured an additional $5.1 million in funding from the Combating Antibiotic-Resistant Bacteria…
